News on Novo Nordisk

Novo Nordisk Shares Surge on New Obesity Drug Results

Read on: The Wall Street Journal

Is Novo Nordisk Stock a Buy After its Collapse?

Read on: Morning Star

Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump

Read on: Quartz

Eli Lilly and Novo Nordisk are tackling heart health next

Read on: Quartz

Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly

Read on: CNBC News

Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action

Read on: CNBC News

Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'

Read on: CNBC News

SAP Overtakes Novo Nordisk to Become Europe's Most Valuable Company

Read on: Morning Star

SAP leapfrogs Novo Nordisk to become Europe's most valuable company

Read on: Financial Times

Novo Nordisk's weight loss drug Wegovy is now cheaper for even more patients

Read on: Quartz

Novo Nordisk expands discounted Wegovy to all cash-paying U.S. customers

Read on: CNBC News

Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure

Read on: CNBC News

Stocks making the biggest moves premarket: JPMorgan Chase, Coinbase, Redfin, Novo Nordisk and more

Read on: CNBC News

Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy

Read on: CNBC News

Novo Nordisk cuts Wegovy prices after similar move by Zepbound maker Eli Lilly

Read on: NBC News

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

Read on: The Washington Times

Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more

Read on: CNBC News

Novo Nordisk slashes Wegovy prices through direct-to-consumer pharmacy

Read on: The Hill

Novo Nordisk slashes Wegovy price for patients lacking insurance benefits

Read on: The Washington Post

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

Read on: The Star

GM, Novo Nordisk, Moderna, Marvell, CrowdStrike: Stocks to watch today

Read on: Quartz

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

Read on: CNBC News

Novo Nordisk stock is having a rough week after that Hims & Hers Super Bowl ad

Read on: Quartz